Found: 20
Select item for more details and to access through your institution.
Anticipating changes in the HER2 status of breast tumours with disease progression—towards better treatment decisions in the new era of HER2-low breast cancers.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 122, doi. 10.1038/s41416-023-02287-x
- By:
- Publication type:
- Article
Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 3, doi. 10.1038/s41416-023-02308-9
- By:
- Publication type:
- Article
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 175, doi. 10.1038/s41416-023-02295-x
- By:
- Publication type:
- Article
Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 54, doi. 10.1038/s41416-023-02286-y
- By:
- Publication type:
- Article
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 61, doi. 10.1038/s41416-023-02293-z
- By:
- Publication type:
- Article
Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 24, doi. 10.1038/s41416-023-02292-0
- By:
- Publication type:
- Article
Correction to: Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 112, doi. 10.1038/s41416-023-02284-0
- By:
- Publication type:
- Article
'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 143, doi. 10.1038/s41416-023-02294-y
- By:
- Publication type:
- Article
NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 135, doi. 10.1038/s41416-023-02285-z
- By:
- Publication type:
- Article
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 38, doi. 10.1038/s41416-023-02279-x
- By:
- Publication type:
- Article
Clinical biomarker-based biological aging and risk of cancer in the UK Biobank.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 94, doi. 10.1038/s41416-023-02288-w
- By:
- Publication type:
- Article
Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 104, doi. 10.1038/s41416-023-02277-z
- By:
- Publication type:
- Article
In silico enhancer mining reveals SNS-032 and EHMT2 inhibitors as therapeutic candidates in high-grade serous ovarian cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 163, doi. 10.1038/s41416-023-02274-2
- By:
- Publication type:
- Article
Modelled mortality benefits of multi-cancer early detection screening in England.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 72, doi. 10.1038/s41416-023-02243-9
- By:
- Publication type:
- Article
"Paradoxical neoantigenic mutations": not simply a driver vs passenger dualism.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Deep learning-based pathology signature could reveal lymph node status and act as a novel prognostic marker across multiple cancer types.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 46, doi. 10.1038/s41416-023-02262-6
- By:
- Publication type:
- Article
The critical roles of m6A RNA methylation in lung cancer: from mechanism to prognosis and therapy.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 8, doi. 10.1038/s41416-023-02246-6
- By:
- Publication type:
- Article
Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 81, doi. 10.1038/s41416-023-02249-3
- By:
- Publication type:
- Article
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 153, doi. 10.1038/s41416-023-02272-4
- By:
- Publication type:
- Article